Results 21 to 30 of about 49,394 (216)

In situ immunopathological events in human cervical intraepithelial neoplasia and cervical cancer: Review

open access: yesTranslational Oncology, 2021
Neoplasia of the cervix represents one of the most common cancers in women. Clinical and molecular research has identified immunological impairment in squamous intraepithelial cervical lesions and cervical cancer patients.
Yenddy N. Carrero   +2 more
doaj   +1 more source

HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression. [PDF]

open access: yesActa Obstet Gynecol Scand
HPV vaccination in women undergoing active surveillance for CIN2 does not offer a protective effect against progression to CIN3+. Women should be informed that vaccination is not a substitute for clinical follow‐up and should be encouraged to adhere to recommended surveillance and treatment protocols Abstract Introduction Human papillomavirus (HPV ...
Eriksen DO   +8 more
europepmc   +2 more sources

Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and meta-analysis [PDF]

open access: yes, 2012
Objective: Bacterial vaginosis (BV), the most common vaginal disorder among women of reproductive age, has been suggested as co-factor in the development of cervical cancer.
De Sutter, Philippe   +6 more
core   +8 more sources

Enhanced diagnostic accuracy of high-grade cervical intraepithelial neoplasia in postmenopausal women through PAX1/JAM3 methylation analysis. [PDF]

open access: yesInt J Cancer
What's new? Cervical cancer screening is challenging in postmenopausal women, partly due to physiological changes that reduce the sensitivity of cytology and colposcopy. This study evaluated the diagnostic performance of combined PAX1 and JAM3 gene methylation testing in a large cohort of postmenopausal women undergoing colposcopy. Compared to cytology
Peng H   +11 more
europepmc   +2 more sources

MicroRNA-551b expression profile in low and high-grade cervical intraepithelial neoplasia [PDF]

open access: yes, 2018
OBJECTIVE: To evaluate the expression of microRNA (miR)-551b in patients with low and high grade cervical intraepithelial neoplasia (CIN) and to find an association with high-risk Human Papillomavirus (HR-HPV) infection-related prognostic biomarkers ...
Bordi, G   +7 more
core   +1 more source

Fractal analysis of cervical intraepithelial neoplasia. [PDF]

open access: yesPLoS ONE, 2014
INTRODUCTION: Cervical intraepithelial neoplasias (CIN) represent precursor lesions of cervical cancer. These neoplastic lesions are traditionally subdivided into three categories CIN 1, CIN 2, and CIN 3, using microscopical criteria.
Markus Fabrizii   +4 more
doaj   +1 more source

When risk becomes illness: The personal and social consequences of cervical intraepithelial neoplasia medical surveillance [PDF]

open access: yes, 2019
[Abstract] Background, After the early detection of cervical intraepithelial neoplasia (CIN), medical surveillance of the precancerous lesions is carried out to control risk factors to avoid the development of cervical cancer. Objective.
Coronado, Carmen   +3 more
core   +1 more source

Clearance of human papillomavirus related anal condylomas after oral and endorectal multistrain probiotic supplementation in an HIV positive male: A case report. [PDF]

open access: yes, 2018
Go to: Introduction: Here we present the case of a 56-year-old human immunodeficiency virus (HIV)-infected man with multiple anal condylomas and positivity for human papilloma virus (HPV) 18 on anal brushing.
Bianchi, L   +7 more
core   +1 more source

Characteristics of vaginal microbiota in various cervical intraepithelial neoplasia: a cross-sectional study

open access: yesJournal of Translational Medicine, 2023
Background Precancerous lesions of cervical cancer exhibit characteristics indicative of natural progression. To prevent overtreatment of patients whose cervical intraepithelial neoplasia (CIN) in regression and to predict the onset of invasive cervical ...
Yiran Liu   +8 more
doaj   +1 more source

Early discharge of low-risk women from cervical screening [PDF]

open access: yes, 2001
Background: The Scottish Cervical Screening Programme currently offers three-yearly screening to all women between the ages of 20 and 60. However, previous studies have indicated that well-screened women over the age of 50 are likely to be at low risk of
Ogilvie, D.
core   +1 more source

Home - About - Disclaimer - Privacy